Fresenius Medical Care AG & Co. KGaA (ETR: FME – Get a rating) was assigned a price target of €62.00 ($65.26) by stock analysts Warburg Research in a note to investors on Tuesday, Borsen Zeitung reports. Warburg Research’s price target points to a potential upside of 7.71% from the company’s previous close.
Several other equity research analysts have also recently published reports on FME. Deutsche Bank Rese… set a price target of €58.00 ($61.05) on Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 research note. Stifel Nicolaus set a €60.00 ($63.16) price target on Fresenius Medical Care AG & Co. KGaA in a Friday, February 4 research note. Credit Suisse Group set a price target of €61.00 ($64.21) on Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 research note. Goldman Sachs Group set a price target of €71.00 ($74.74) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 research note. Finally, Barclays set a price target of €68.00 ($71.58) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, April 26 research note. One equity research analyst has assigned the stock a sell rating, two have issued a hold rating and two have assigned the company a buy rating. According to MarketBeat.com, Fresenius Medical Care AG & Co. KGaA currently has an average rating of “Hold” and a consensus target price of €64.74 ($68.15).
Shares of Share Fresenius Medical Care AG & Co. KGaA fell €1.02 ($1.07) on Tuesday, reaching €57.56 ($60.59). The stock had a trading volume of 512,462 shares, compared to an average volume of 704,197. The company has a quick ratio of 0.76, a current ratio of 1.10 and a leverage ratio of 95.29. . The stock has a market cap of $16.87 billion and a price-to-earnings ratio of 17.39. The company’s 50-day moving average is €59.80 and its two-hundred-day moving average is €58.52. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €50.98 ($53.66) and a 12-month high of €71.14 ($74.88).
About Fresenius Medical Care AG & Co. KGaA (Get a rating)
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.
Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .